Ketogenic diet restrains aging-induced exacerbation of coronavirus infection in mice

  1. Seungjin Ryu
  2. Irina Shchukina
  3. Yun-Hee Youm
  4. Hua Qing
  5. Brandon Hilliard
  6. Tamara Dlugos
  7. Xinbo Zhang
  8. Yuki Yasumoto
  9. Carmen J Booth
  10. Carlos Fernández-Hernando
  11. Yajaira Suárez
  12. Kamal Khanna
  13. Tamas L Horvath
  14. Marcelo O Dietrich
  15. Maxim N Artyomov
  16. Andrew Wang  Is a corresponding author
  17. Vishwa Deep Dixit  Is a corresponding author
  1. Yale University, United States
  2. Washington University School of Medicine, United States
  3. Yale University School of Medicine, United States
  4. New York University Langone Health, United States
  5. Yale School of Medicine, United States

Abstract

Increasing age is the strongest predictor of risk of COVID-19 severity and mortality. Immunometabolic switch from glycolysis to ketolysis protects against inflammatory damage and influenza infection in adults. To investigate how age compromises defense against coronavirus infection, and whether a pro-longevity ketogenic-diet (KD) impacts immune-surveillance, we developed an aging model of natural murine beta coronavirus (mCoV) infection with mouse hepatitis virus strain-A59 (MHV-A59). When inoculated intranasally, mCoV is pneumotropic and recapitulates several clinical hallmarks of COVID-19 infection. Aged mCoV-A59-infected mice have increased mortality and higher systemic inflammation in the heart, adipose tissue and hypothalamus, including neutrophilia and loss of γδ T cells in lungs. Activation of ketogenesis in aged mice expands tissue protective γδ T cells, deactivates the NLRP3 inflammasome and decreases pathogenic monocytes in lungs of infected aged mice. These data establish harnessing of the ketogenic immunometabolic checkpoint as a potential treatment against coronavirus infection in the aged.

Data availability

The single cell RNA-sequencing and bulk RNA-sequencing data has been uploaded to Gene Expression Omnibus (GSE155346 and GSE155347) respectively.

The following data sets were generated

Article and author information

Author details

  1. Seungjin Ryu

    Comparative Medicine and Immunobiology, Yale University, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Irina Shchukina

    Pathology and Immunology, Washington University School of Medicine, St. Louis, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Yun-Hee Youm

    Comparative Medicine and Immunobiology, Yale University, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Hua Qing

    Internal Medicine, Yale University, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Brandon Hilliard

    Internal Medicine, Yale University, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Tamara Dlugos

    Comparative Medicine and Immunobiology, Yale University, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Xinbo Zhang

    Comparative Medicine, Yale University, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Yuki Yasumoto

    Comparative Medicine, Yale University, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Carmen J Booth

    Department of Comparative Medicine, Yale University School of Medicine, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Carlos Fernández-Hernando

    Comparative Medicine and Program in Integrative Cell Signaling and Neurobiology of Metabolism, Yale University, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Yajaira Suárez

    Comparative Medicine and Program in Integrative Cell Signaling and Neurobiology of Metabolism, Yale University, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Kamal Khanna

    New York University Langone Health, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  13. Tamas L Horvath

    Program in Integrative Cell Signaling and Neurobiology of Metabolism, Yale University School of Medicine, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7522-4602
  14. Marcelo O Dietrich

    Comparative Medicine, Yale University School of Medicine, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9781-2221
  15. Maxim N Artyomov

    Department of Pathology and Immunology, Washington University School of Medicine, St Louis, United States
    Competing interests
    The authors declare that no competing interests exist.
  16. Andrew Wang

    Yale School of Medicine, New Haven, United States
    For correspondence
    andrew.wang@yale.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6951-8081
  17. Vishwa Deep Dixit

    Comparative Medicine and Immunobiology, Yale University School of Medicine, New Haven, United States
    For correspondence
    vishwa.dixit@yale.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5341-6494

Funding

National Institute on Aging (P01AG051459)

  • Vishwa Deep Dixit

National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR070811)

  • Vishwa Deep Dixit

American Federation for Aging Research (Glenn Foundation for Medical Research Postdoctoral Fellowships in Aging Research)

  • Seungjin Ryu

National Institute of Allergy and Infectious Diseases (1K08AI128745)

  • Andrew Wang

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Chyung-Ru Wang, Northwestern University, United States

Ethics

Animal experimentation: All experiments and animal use were conducted in compliance with the National Institute of Health Guide for the Care and Use of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee (IACUC) protocol (#2019-11572 and 2020-20149) of Yale University.

Version history

  1. Received: January 13, 2021
  2. Accepted: June 15, 2021
  3. Accepted Manuscript published: June 21, 2021 (version 1)
  4. Version of Record published: June 30, 2021 (version 2)

Copyright

© 2021, Ryu et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 7,933
    views
  • 473
    downloads
  • 37
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Seungjin Ryu
  2. Irina Shchukina
  3. Yun-Hee Youm
  4. Hua Qing
  5. Brandon Hilliard
  6. Tamara Dlugos
  7. Xinbo Zhang
  8. Yuki Yasumoto
  9. Carmen J Booth
  10. Carlos Fernández-Hernando
  11. Yajaira Suárez
  12. Kamal Khanna
  13. Tamas L Horvath
  14. Marcelo O Dietrich
  15. Maxim N Artyomov
  16. Andrew Wang
  17. Vishwa Deep Dixit
(2021)
Ketogenic diet restrains aging-induced exacerbation of coronavirus infection in mice
eLife 10:e66522.
https://doi.org/10.7554/eLife.66522

Share this article

https://doi.org/10.7554/eLife.66522

Further reading

    1. Immunology and Inflammation
    Phillip A Erice, Xinyan Huang ... Antony Rodriguez
    Research Article

    Environmental air irritants including nanosized carbon black (nCB) can drive systemic inflammation, promoting chronic obstructive pulmonary disease (COPD) and emphysema development. The let-7 microRNA (Mirlet7 miRNA) family is associated with IL-17-driven T cell inflammation, a canonical signature of lung inflammation. Recent evidence suggests the Mirlet7 family is downregulated in patients with COPD, however, whether this repression conveys a functional consequence on emphysema pathology has not been elucidated. Here, we show that overall expression of the Mirlet7 clusters, Mirlet7b/Mirlet7c2 and Mirlet7a1/Mirlet7f1/Mirlet7d, are reduced in the lungs and T cells of smokers with emphysema as well as in mice with cigarette smoke (CS)- or nCB-elicited emphysema. We demonstrate that loss of the Mirlet7b/Mirlet7c2 cluster in T cells predisposed mice to exaggerated CS- or nCB-elicited emphysema. Furthermore, ablation of the Mirlet7b/Mirlet7c2 cluster enhanced CD8+IL17a+ T cells (Tc17) formation in emphysema development in mice. Additionally, transgenic mice overexpressing Mirlet7g in T cells are resistant to Tc17 and CD4+IL17a+ T cells (Th17) development when exposed to nCB. Mechanistically, our findings reveal the master regulator of Tc17/Th17 differentiation, RAR-related orphan receptor gamma t (RORγt), as a direct target of Mirlet7 in T cells. Overall, our findings shed light on the Mirlet7/RORγt axis with Mirlet7 acting as a molecular brake in the generation of Tc17 cells and suggest a novel therapeutic approach for tempering the augmented IL-17-mediated response in emphysema.

    1. Immunology and Inflammation
    Xiuyuan Lu, Hiroki Hayashi ... Sho Yamasaki
    Research Article

    SARS-CoV-2 vaccines have been used worldwide to combat COVID-19 pandemic. To elucidate the factors that determine the longevity of spike (S)-specific antibodies, we traced the characteristics of S-specific T cell clonotypes together with their epitopes and anti-S antibody titers before and after BNT162b2 vaccination over time. T cell receptor (TCR) αβ sequences and mRNA expression of the S-responded T cells were investigated using single-cell TCR- and RNA-sequencing. Highly expanded 199 TCR clonotypes upon stimulation with S peptide pools were reconstituted into a reporter T cell line for the determination of epitopes and restricting HLAs. Among them, we could determine 78 S epitopes, most of which were conserved in variants of concern (VOCs). After the 2nd vaccination, T cell clonotypes highly responsive to recall S stimulation were polarized to follicular helper T (Tfh)-like cells in donors exhibiting sustained anti-S antibody titers (designated as ‘sustainers’), but not in ‘decliners’. Even before vaccination, S-reactive CD4+ T cell clonotypes did exist, most of which cross-reacted with environmental or symbiotic microbes. However, these clonotypes contracted after vaccination. Conversely, S-reactive clonotypes dominated after vaccination were undetectable in pre-vaccinated T cell pool, suggesting that highly responding S-reactive T cells were established by vaccination from rare clonotypes. These results suggest that de novo acquisition of memory Tfh-like cells upon vaccination may contribute to the longevity of anti-S antibody titers.